Cited by 1,023TGF-β signaling in diseasesT-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 86 of the 87 references it cites were found in a registry or an index.

TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression

Open access

Yang, Li, Pang, Yanli, Moses, Harold L.·2010·Trends in Immunology

DOI 10.1016/j.it.2010.04.002PMC PMC2891151

Open this paper in CoChat — free account

Abstract

Transforming growth factor beta (TGF-beta) plays an important role in tumor initiation and progression, functioning as both a suppressor and a promoter. The mechanisms underlying this dual role of TGF-beta remain unclear. TGF-beta exerts systemic immune suppression and inhibits host immunosurveillance. Neutralizing TGF-beta enhances CD8+ T-cell- and NK-cell-mediated anti-tumor immune responses. It also increases neutrophil-attracting chemokines resulting in recruitment and activation of neutrophils with an antitumor phenotype. In addition to its systemic effects, TGF-beta regulates infiltration of inflammatory/immune cells and cancer-associated fibroblasts in the tumor microenvironment causing direct changes in tumor cells. Understanding TGF-beta regulation at the interface of tumor and host immunity should provide insights into developing effective TGF-beta antagonists and biomarkers for patient selection and efficacy of TGF-beta antagonist treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.it.2010.04.002

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cancer-related inflammation
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,498
IL-17 and th17 cells
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
TGFβ in Cancer
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L. E., Worthen, G. S., & Albelda, S. Μ. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,470
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087

Show all 87 references

Sorted by citations

Items 501–600 of 1,000

TGF-β1 and hypoxia-dependent expression of MKP-1 leads tumor resistance to death receptor-mediated cell death
Park, J., Lee, J., Kang, W., Chang, S.-Y., Shin, E.-C., & Choi, C. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.42 · Cited by 19
TGF-β1 induces HMGA1 expression in human breast cancer cells: Implications of the involvement of HMGA1 in TGF-β signaling
Zu, X., Zhong, J., Tan, J., TAN, L., Yang, D. Y., Zhang, Q., DING, W., Liu, W., Wen, G., Liu, J., et al. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2062 · Cited by 19
Immunity and autoimmunity: revising the concepts of response to breast cancer
Curigliano, G. (2011) · The Breast · doi:10.1016/s0960-9776(11)70298-3 · Cited by 19
Transforming Growth Factor β is a Poor Prognostic Factor and Inhibits the Favorable Prognostic Value of CD8+ CTL in Human Hepatocellular Carcinoma
Huang, C., Wang, H., Liao, W., Han, F., Li, Y., Chen, S.-W., & Lao, X. (2017) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000166 · Cited by 20
Cystatin C takes part in melanoma-microglia cross-talk: possible implications for brain metastasis
Moshe, A., Izraely, S., Sagi‐Assif, O., Prakash, R., Telerman, A., Meshel, T., Carmichael, S. T., & Witz, I. P. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9891-0 · Cited by 18
Alteration of tumor associated neutrophils by PIK3CA expression in endometrial carcinoma from TCGA data
Pan, Y., Li, J., Liu, Y., Han, Y., & Deng, Q. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0557-6 · Cited by 19
S1P signaling, its interactions and cross-talks with other partners and therapeutic importance in colorectal cancer
Sattar, R. S. A., Sumi, M. P., Nimisha, Apurva, A., Kumar, A., Sharma, A. K., Ahmad, E., Ali, A., Mahajan, B., & Saluja, S. S. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110080 · Cited by 19
TGF-β inhibits IL-7-induced proliferation in memory but not naive human CD4+ T cells
Nguyen, T. P., & Sieg, S. F. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1216-520rr · Cited by 19
Transcutaneous Vagal Nerve Stimulation Alone or in Combination With Radiotherapy Stimulates Lung Tumor Infiltrating Lymphocytes But Fails to Suppress Tumor Growth
Reijmen, E., de Mey, S., Damme, H. V., Ridder, K. D., Gevaert, T., Blay, E. D., Bouwens, L., Collen, C., Decoster, L., Couck, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.772555 · Cited by 18
CAR-T cells for cancer immunotherapy
Xie, Y., Li, X., Wu, J., Zeng, H., Boucetta, H., Wang, B., Yang, P., & He, W. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.108202 · Cited by 18
The role of matrix metalloproteinase-2 in the metastatic cascade: a review
Murray, N. P. (2024) · ONCOLOGIE · doi:10.1515/oncologie-2023-0368 · Cited by 19
Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery
Lansberry, T. R., & Stabler, C. L. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115179 · Cited by 20
Adrenal gland macrophages regulate glucocorticoid production through Trem2 and TGF-β
Xu, Y., Patterson, M. T., Dolfi, B., Zhu, A., Bertola, A., Schrank, P. R., Gallerand, A., Kennedy, A. E., Hillman, H., Dinh, L., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.174746 · Cited by 20
Disrupting Smad3 potentiates immunostimulatory function of NK cells against lung carcinoma by promoting GM-CSF production
Lian, G., Wang, Q., Mak, T. S., Huang, X.-R., Yu, X., & Lan, H. Y. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05290-4 · Cited by 18
Metabolic Nanoregulators Induce Ferroptosis and Change Metabolite Flow to Reverse Immunosuppressive Tumor Microenvironment
Wang, Y., Chen, Q., Luo, Y., Qu, Y., Li, X., Song, H., Li, C., Zhang, Y., Sun, T., & Jiang, C. (2024) · ACS Nano · doi:10.1021/acsnano.4c13425 · Cited by 18
Genetically Modified T Cells to Target Glioblastoma
Krebs, S. S., Rodríguez-Cruz, T., DeRenzo, C. C., & Gottschalk, S. M. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00322 · Cited by 20
TGF-β Physiology as a Novel Therapeutic Target Regarding Autoimmune Thyroid Diseases: Where Do We Stand and What to Expect
Kardalas, E., Maraka, S., Papagianni, M., Paltoglou, G., Siristatidis, C. S., & Mastorakos, G. P. (2021) · Medicina · doi:10.3390/medicina57060621 · Cited by 18
Combining Oncolytic Viruses and Small Molecule Therapeutics: Mutual Benefits
Spiesschaert, B., Angerer, K., Park, J., & Wollmann, G. (2021) · Cancers · doi:10.3390/cancers13143386 · Cited by 22
Tumor-Associated Mast Cells in Urothelial Bladder Cancer: Optimizing Immuno-Oncology
Choi, H. W., Naskar, M., Seo, H. K., & Lee, H. W. (2021) · Biomedicines · doi:10.3390/biomedicines9111500 · Cited by 18
A possible mechanism of impaired NK cytotoxicity in cancer patients: Down-regulation of DAP10 by TGF-β1
Lee, J.-C., Lee, K., Ahn, Y., Suh, B., & Heo, D. S. (2011) · Tumori Journal · doi:10.1177/030089161109700316 · Cited by 18
Genetically Modified T-Cell Therapy for Osteosarcoma
DeRenzo, C. C., & Gottschalk, S. M. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_18 · Cited by 18
A possible mechanism of impaired NK cytotoxicity in cancer patients: Down-regulation of DAP10 by TGF-β1
Lee, J. C., Lee, K., Ahn, Y., Suh, B., & Heo, D. S. (2011) · Tumori · doi:10.1700/912.10124 · Cited by 18
Expression Profiles of SnoN in Normal and Cancerous Human Tissues Support Its Tumor Suppressor Role in Human Cancer
Jahchan, N. S., Ouyang, G., & Luo, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055794 · Cited by 18
TGF-β favors bone marrow-derived dendritic cells to acquire tolerogenic properties
Song, S., Yuan, P., Chen, J., Fu, J., Wu, H., Lu, J., & Wei, W. (2014) · Immunological Investigations · doi:10.3109/08820139.2013.879172 · Cited by 18
Population Pharmacokinetic Analysis of Bintrafusp Alfa in Different Cancer Types
Wilkins, J. J., Vugmeyster, Y., Dussault, I., Girard, P., & Khandelwal, A. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01018-0 · Cited by 18
Molecular Mechanisms of Wound Healing: The Role of Medicinal Plants
Esad, M., Dimov, I., Choneva, M., Popova, M., Kokova, V., Apostolova, E., & Bivolarska, A. (2025) · Life · doi:10.3390/life15111748 · Cited by 20
Genome editing of immune cells using CRISPR/Cas9
Kim, S., Hupperetz, C., Kim, C. H., & Kim, C. H. (2021) · BMB Reports · doi:10.5483/bmbrep.2021.54.1.245 · Cited by 21
Immunogenomic pan-cancer landscape reveals immune escape mechanisms and immunoediting histories
Mizuno, S., Yamaguchi, R., Hasegawa, T., Hayashi, S., Fujita, M., Zhang, F., Koh, Y., Lee, S.-Y., Yoon, S., Shimizu, E., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-95287-x · Cited by 21
ToP: A Trend-of-Disease-Progression Procedure Works Well for Identifying Cancer Genes from Multi-State Cohort Gene Expression Data for Human Colorectal Cancer
Chung, F.-H., Lee, H. H., & Lee, H.-C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065683 · Cited by 17
Post-hoc evaluation of peripheral blood natural killer cell cytotoxicity in predicting the risk of recurrent pregnancy losses and repeated implantation failures
Salazar, M. D., Wang, W. J., Skariah, A. M., He, Q., Field, K., Nixon, M., Reed, R., Dambaeva, S. V., Beaman, K. D., Gilman‐Sachs, A., et al. (2022) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2022.103487 · Cited by 17
Trophic and neurotrophic factors in human pituitary adenomas (Review)
Spoletini, M., Taurone, S., Tombolini, M., Minni, A., ALTISSIMI, G., Wierzbicki, V., Giangaspero, F., Parnigotto, P. P., Artico, M., Bardella, L., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4120 · Cited by 17
Nanosecond pulsed electric field inhibits malignant melanoma growth by inducing the change of systemic immunity
Zhang, X., Zhang, Y., Chen, J., Wu, Y., Zhang, J., & Wang, J. (2019) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.22976 · Cited by 17
TGF-β regulated leukemia cell susceptibility against NK targeting through the down-regulation of the CD48 expression
Huang, C.-H., Liao, Y., Chiou, T.-J., Huang, H.-T., Lin, Y.-H., & Twu, Y. (2019) · Immunobiology · doi:10.1016/j.imbio.2019.07.002 · Cited by 18
Breaking hypoxic barrier: Oxygen-supplied nanomaterials for enhanced T cell-mediated tumor immunotherapy
Xiang, S., Zhan, H., Zhan, J., Li, X., Lin, X., & Sun, W. (2025) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2025.100400 · Cited by 16
Pan-cancer analysis identifies adhesion G protein-coupled receptor G6 as a potential prognostic and immunotherapeutic biomarker with its functional validation
Zhu, J., Wang, Y., Huang, Q., & Liu, Z. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149128 · Cited by 18
Effect of miR-143 on the apoptosis of osteosarcoma cells.
Liu, H., Wang, H., Liu, H., & Chen, Y. (2015) · PubMed Central · Cited by 16
TGF-β2 is a Prognostic Biomarker Correlated with Immune Cell Infiltration in Colorectal Cancer
Tu, Y., Han, J., Dong, Q.-J., Chai, R., Li, N., Lu, Q., Xiao, Z., Guo, Y., Wan, Z., & Xu, Q. (2020) · Medicine · doi:10.1097/md.0000000000023024 · Cited by 16
miRNA in Machine-learning-based Diagnostics of Cancers
Kang, W., Kouznetsova, V. L., & Tsigelny, I. F. (2022) · Cancer Screening and Prevention · doi:10.14218/csp.2021.00001 · Cited by 16
LRRC superfamily expression in stromal cells predicts the clinical prognosis and platinum resistance of ovarian cancer
Zhu, X., Shijing, Y. O. U., Du, X., Song, K., Lv, T., Zhao, H., & Yao, Q. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01435-9 · Cited by 20
Patient-derived spheroids and patient-derived organoids simulate evolutions of lung cancer
Surina, Tanggis, Suzuki, T., Hisata, S., Fujita, K., Fujiwara, S., Liu, F., Fukushima, N., Suzuki, T., Mato, N., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13829 · Cited by 16
The PD-1/PD-L1 Axis in the Biology of MASLD
Pipitone, R. M., Lupo, G., Zito, R., Javed, A., Petta, S., Pennisi, G., & Grimaudo, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073671 · Cited by 20
Complex immune microenvironment of chordoma: a road map for future treatment
Niu, H., Zheng, B., Zou, M., & Zheng, B. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009313 · Cited by 16
Single-cell dissection of multifocal bladder cancer reveals malignant and immune cells variation between primary and recurrent tumor lesions
Liu, S., Feng, C., Tan, L., Zhang, D., Li, Y., Han, Y., & Wang, C. (2024) · Communications Biology · doi:10.1038/s42003-024-07343-7 · Cited by 18
Working out mechanisms of controlled/physiologic inflammation in the GI tract
Rabinowitz, K. M., & Mayer, L. (2012) · Immunologic Research · doi:10.1007/s12026-012-8315-5 · Cited by 16
Harnessing High Density Lipoproteins to Block Transforming Growth Factor Beta and to Inhibit the Growth of Liver Tumor Metastases
Medina‐Echeverz, J., Fioravanti, J., Díaz‐Valdés, N., Frank, K., Aranda, F., Gomar, C., Ardaiz, N., Dotor, J., Umansky, V., Prìeto, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096799 · Cited by 16
Aqueous extract of Arctium lappa L. root (burdock) enhances chondrogenesis in human bone marrow-derived mesenchymal stem cells
Wu, K., Weng, H.-K., Hsu, Y.-S., Huang, P.-J., & Wang, Y.-K. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-03158-1 · Cited by 20
The role of SYT-SSX fusion gene in tumorigenesis of synovial sarcoma
Xiao, F., Huang, Y., Zhang, Z., Wang, N., Yao, Q., Pang, L., Li, F., & Yan, Q. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153416 · Cited by 16
Therapeutic Associations Comprising Anti-PD-1/PD-L1 in Breast Cancer: Clinical Challenges and Perspectives
Ledys, F., Kalfeist, L., Galland, L., Limagne, E., & Ladoire, S. (2021) · Cancers · doi:10.3390/cancers13235999 · Cited by 18
Pancreatic cancer, treatment options, and GI-4000
Hartley, M. L., Bade, N. A., Prins, P., Ampie, L., & Marshall, J. L. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1011017 · Cited by 16
Transforming growth factor β1 and Fas ligand synergistically enhance immune tolerance in dendritic cells in liver transplantation
Qiu, M., Chen, Y., Chen, L., Zeng, J., & Liu, J. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.05.040 · Cited by 16
Potentiating tumor immunity using aptamer-targeted RNAi to render CD8 + T cells resistant to TGFβ inhibition
Puplampu-Dove, Y., Gefen, T., Rajagopalan, A. R., Muheramagic, D., Schrand, B., & Gilboa, E. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1349588 · Cited by 16
Roles of Transforming Growth Factor-β in Graft-versus-Host and Graft-versus-Tumor Effects
Carli, C., Giroux, M., & Delisle, J. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2012.01.020 · Cited by 16
Antitumor Research Based on Drug Delivery Carriers: Reversing the Polarization of Tumor-Associated Macrophages
Cao, X., Wan, S., Wu, B., Liu, Z., Xu, L., Ding, Y. J., & Huang, H. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c01277 · Cited by 17
The hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy
Tufail, M., Gong, K., Ijaz, B., Patel, H. H., Lui, W., Wang, X., & Li, J. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101355 · Cited by 16
Effect of nitric oxide inhibition in Bacillus Calmette-Guerin bladder cancer treatment
Langle, Y., Balarino, N., Belgorosky, D., Morgado, P., Sandes, E. O., Marino, L., Bilbao, E. A. R., Zambrano, M., Lodillinsky, C., & Eiján, A. M. (2020) · Nitric Oxide · doi:10.1016/j.niox.2020.03.003 · Cited by 15
A Cell-Based Systematic Review on the Role of Annexin A1 in Triple-Negative Breast Cancers
Pearanpan, L., Nordin, F. J., Siew, E. L., Kumolosasi, E., Hanif, E. A. M., Masre, S. F., Chua, E. W., Cheng, H. S., & Rajab, N. F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158256 · Cited by 15
Cyclin‐dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial‐mesenchymal transition‐like process in glioma by activating TGFβ/SMAD signaling
Feng, F., Zhao, Z., Cai, X., Heng, X., & Ma, X. (2022) · Cancer Medicine · doi:10.1002/cam4.5381 · Cited by 15
Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial
Chiang, C., Lam, T., Li, J. C. B., Chan, S.-K., Helali, A. E., Lee, Y. Y. P., Law, L. H. T., Zheng, D., Lo, A. W. I., Kam, N., et al. (2023) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2023.100898 · Cited by 15
Combined signature of N7-methylguanosine regulators with their related genes and the tumor microenvironment: a prognostic and therapeutic biomarker for breast cancer
Li, T., Chen, Z., Wang, Z., Lu, J., & Chen, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1260195 · Cited by 15
The effect of CT26 tumor-derived TGF-β on the balance of tumor growth and immunity
Owyang, S. Y., Zhang, M., Walkup, G. A., Chen, G. E., Grasberger, H., Zaatari, M. E., & Kao, J. Y. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.08.024 · Cited by 16
Tumor mechanisms of resistance to immune attack
Zahavi, D. J., & Weiner, L. M. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.03.009 · Cited by 15
MicroRNA-155 governs SHIP-1 expression and localization in NK cells and regulates subsequent infiltration into murine AT3 mammary carcinoma
Kandell, W. M., Donatelli, S. S., Trinh, T. L., Calescibetta, A. R., So, T., Tu, N., Gilvary, D. L., Chen, X., Cheng, P., Adams, W. A., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0225820 · Cited by 17
CNOT7 depletion reverses natural killer cell resistance by modulating the tumor immune microenvironment of hepatocellular carcinoma
Ren, C., Ren, X., Cao, D., Zhao, H., Zhai, Z., Li, H., Li, Y., Fu, X., He, J., & Zhao, H. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12836 · Cited by 15
Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer
Mezi, S., Botticelli, A., Pomati, G., Cerbelli, B., Scagnoli, S., Amirhassankhani, S., d’Amati, G., & Marchetti, P. (2021) · Cancers · doi:10.3390/cancers13051080 · Cited by 17
MIR503HG: A potential diagnostic and therapeutic target in human diseases
Han, X., Li, B., & Zhang, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114314 · Cited by 16
Modulating T-cell-based cancer immunotherapy via particulate systems
Truong, D. H., Tran, T. T. P., Nguyen, H. T., Phung, C. D., Pham, T. T., Yong, C. S., Kim, J. O., & Tran, T. H. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1474360 · Cited by 15
Tumour Microenvironment: Overview with an Emphasis on the Colorectal Liver Metastasis Pathway
Giakoustidis, A. E., Mudan, S., & Hagemann, T. (2014) · Cancer Microenvironment · doi:10.1007/s12307-014-0155-5 · Cited by 16
Unraveling tumor microenvironment heterogeneity in malignant pleural mesothelioma identifies biologically distinct immune subtypes enabling prognosis determination
Yang, K., Yang, T., Yang, T., Yuan, Y., & Li, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.995651 · Cited by 14
Computed tomography-detected extramural venous invasion-related gene signature: a potential negative biomarker of immune checkpoint inhibitor treatment in patients with gastric cancer
Yang, H., Gou, X., Feng, C., Zhang, Y., Chai, F., Hong, N., Ye, Y., Wang, Y., Gao, B., & Cheng, J. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-022-03845-2 · Cited by 14
An integrated bioinformatic analysis of bulk and single-cell sequencing clarifies immune microenvironment and metabolic profiles of lung adenocarcinoma to predict immunotherapy efficacy
Li, M., Zhou, B., & Zheng, C. J. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1163314 · Cited by 15
NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells
Petillo, S., Sproviero, E., Loconte, L., Cuollo, L., Zingoni, A., Molfetta, R., Fionda, C., Soriani, A., Cerboni, C., Petrucci, M. T., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05949-z · Cited by 14
Heterogeneity of the tumor immune microenvironment and clinical interventions
Jin, Z., Zhou, Q., Cheng, J., Jia, Q., & Zhu, B. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-1015-9 · Cited by 14
Carrier-free multifunctional nanomedicine for enhanced hyperthermic intraperitoneal chemotherapy against abdominal pelvic tumors
Fang, H., Zhang, L., Wu, Y., Chen, L., Zheng, Z., Zheng, Z., Wang, Y., Yang, Y., & Chen, Q. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.155781 · Cited by 14
Superior antitumor immune response achieved with proton over photon immunoradiotherapy is amplified by the nanoradioenhancer NBTXR3
Hu, Y. Y., Paris, S., Sahoo, N., Wang, Q., Wang, Q., Barsoumian, H. B., Huang, A., SILVA, J. D., Bienassis, C., Leyton, C. S. K., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02855-0 · Cited by 14
Is thrombocytosis a valid indicator of advanced stage and high mortality of gynecological cancer?
Andersen, C. L., Eskelund, C. W., Siersma, V., Felding, P., Lind, B., Palmblad, J. E. W., Bjerrum, O. W., Friis, S., Hasselbalch, H. C., & Olivarius, N. D. F. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.09.017 · Cited by 14
The prognostic importance of TGF-β, TGF-β receptor, and fascin in childhood solid tumors
Tanyıldız, H. G., Kaygusuz, G., Ünal, E., Taçyıldız, N., Dincaslan, H. U., & Yavuz, G. (2017) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2017.1363838 · Cited by 14
Systems Biology Approaches to Investigate Genetic and Epigenetic Molecular Progression Mechanisms for Identifying Gene Expression Signatures in Papillary Thyroid Cancer
Yeh, S., Lin, C., Li, C., & Chen, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102536 · Cited by 15
Lysyl oxidase expression is regulated by the H3K27 demethylase Jmjd3 in tumor-associated M2-like macrophages
Takemoto, R., Kamiya, T., Hara, H., & Adachi, T. (2020) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.19-67 · Cited by 14
Metabolites profiling and pharmacokinetics of troxipide and its pharmacodynamics in rats with gastric ulcer
Guo, H., Chen, B., Yan, Z., Gao, J. X., Tang, J., & Zhou, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-70312-7 · Cited by 14
Genetically-engineered “all-in-one” vaccine platform for cancer immunotherapy
Wu, A., Chen, Y., Wang, H., Chang, Y., Zhang, M., Zhao, P., Tang, Y., Xu, Q., Zhu, Z., Cao, Y., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.001 · Cited by 14
Modeling cancer immunoediting in tumor microenvironment with system characterization through the ising-model Hamiltonian
Rojas‐Domínguez, A., Arroyo-Duarte, R., Rincón-Vieyra, F., & Alvarado, M. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04731-w · Cited by 14
Lymphatic vasculature in ovarian cancer
Pal, S., Bhowmick, S., Sharma, A., Sierra-Fonseca, J. A., Mondal, S., Afolabi, F., & Roy, D. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188950 · Cited by 14
P130cas is required for TGF-β1-mediated epithelial-mesenchymal transition in lung cancer
Deng, B., Tan, Q., Wang, R., Jiang, Y., Zhou, J., & Huang, W. (2014) · Oncology Letters · doi:10.3892/ol.2014.2123 · Cited by 14
The timing of TGF-β inhibition affects the generation of antigen-specific CD8+ T Cells
Quatromoni, J. G., Suzuki, E., Okusanya, O. T., Judy, B. F., Bhojnagarwala, P. S., Venegas, O. G., Eruslanov, E. B., Predina, J. D., Albelda, S. Μ., & Singhal, S. K. (2013) · BMC Immunology · doi:10.1186/1471-2172-14-30 · Cited by 14
Suppression of established hepatocarcinoma in adjuvant only immunotherapy: alum triggers anti-tumor CD8+ T cell response
Wang, B., Wang, X., Wen, Y., Fu, J., Wang, H., Ma, Z., Shi, Y., & Wang, B. (2015) · Scientific Reports · doi:10.1038/srep17695 · Cited by 14
Tumor-derived immuno-modulators induce overlapping pro-tolerogenic gene expression signatures in human dendritic cells
Trojandt, S., Bellinghausen, I., Reske‐Kunz, A. B., & Bros, M. (2016) · Human Immunology · doi:10.1016/j.humimm.2016.08.014 · Cited by 14
Intermittent dosing of the transforming growth factor beta receptor 1 inhibitor, BMS‐986260, mitigates class‐based cardiovascular toxicity in dogs but not rats
Rak, G. D., White, M. R., Augustine‐Rauch, K. A., Newsome, C., Graziano, M. J., & Schulze, G. E. (2020) · Journal of Applied Toxicology · doi:10.1002/jat.3954 · Cited by 14
Consequences of Epithelial or Stromal TGFβ1 Depletion in the Mammary Gland
Nguyen, D. H. A., Martinez‐Ruiz, H., & Barcellos‐Hoff, M. H. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9218-0 · Cited by 14
Insights into the Human Microbiome and Its Connections with Prostate Cancer
Munteanu, R. A., Feder, R., Onaciu, A., Munteanu, V. C., Iuga, C. A., & Gulei, D. (2023) · Cancers · doi:10.3390/cancers15092539 · Cited by 13
A Novel TGF-β-Related Signature for Predicting Prognosis, Tumor Microenvironment, and Therapeutic Response in Colorectal Cancer
Tao, B., Yi, C., Ma, Y., Li, Y., Zhang, B., Geng, Y., Chen, Z., Ma, X., & Chen, J. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10591-7 · Cited by 13
Valproic acid triggers radiation-induced abscopal effect by modulating the unirradiated tumor immune microenvironment in a rat model of breast cancer
Jin, L., Duan, W., Cai, Z., LIM, D. J., & Feng, Z. (2021) · Journal of Radiation Research · doi:10.1093/jrr/rrab037 · Cited by 13
TGF-β-p-STAT1-LAIR2 axis has a “self-rescue” role for exhausted CD8+ T cells in hepatocellular carcinoma
Pan, B., Wang, Z., Yao, Y., Ke, X., Shen, S., Chen, W., Zhang, X., Qiu, J., Wu, X., & Tang, N. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00830-9 · Cited by 13
The Amazing Power of Cancer Cells to Recapitulate Extraembryonic Functions: The Cuckoo's Tricks
Arias, J. I., Aller, M., Prieto, I., Arias, A., de Julian, Z., Yang, H., & Árias, J. (2011) · Journal of Oncology · doi:10.1155/2012/521284 · Cited by 13
RNF111/Arkadia is regulated by DNA methylation and affects TGF-β/Smad signaling associated invasion in NSCLC cells
Chen, H., Yang, T., Lei, Z., Wang, L., Yang, H., Tong, X., Yang, W., Zhao, J., Gu, Y., Chen, Y., et al. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.07.010 · Cited by 13
Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients?
El-Fattah, A. A. A., Sadik, N. A. H., Shaker, O. G., & Kamal, A. M. (2016) · Tumor Biology · doi:10.1007/s13277-016-4813-8 · Cited by 13
Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes
Vitiello, G. A. F., Amarante, M. K., Hirata, B. K. B., Campos, C. Z., de Oliveira, K. B., Guembarovski, R. L., & Watanabe, M. A. E. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05370-1 · Cited by 13
The Suppression of Th1 Response by Inducing TGF-β1 From Regulatory T Cells in Bovine Mycoplasmosis
Sajiki, Y., Konnai, S., Goto, S., Okagawa, T., Ohira, K., Shimakura, H., Maekawa, N., Gondaira, S., Higuchi, H., Tajima, M., et al. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.609443 · Cited by 13
TGF-beta antiproliferative effects in tumor suppression
Law, B. K. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s297 · Cited by 13
Genetically Modified T-Cell Therapy for Osteosarcoma: Into the Roaring 2020s
DeRenzo, C., & Gottschalk, S. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-43032-0_10 · Cited by 12
Sildenafil Inhibits the Growth and Epithelial-to-mesenchymal Transition of Cervical Cancer via the TGF-β1/Smad2/3 Pathway
Ke, X., Liu, P., Pei, J., Li, L., & Li, J. (2022) · Current Cancer Drug Targets · doi:10.2174/1568009622666220816114543 · Cited by 13

Authors: Yang, L., Pang, Y., & Moses, H. L.
Affiliations: National Institutes of Health (US)
Vanderbilt University (US)
ORCID: Pang, Yanli
Moses, Harold L.
Venue: Trends in Immunology
Publisher: Elsevier BV
Published: 2010-06
Volume: 31
Issue: 6
Pages: 220-227
ISSN: 1471-4906 (ISSN-L)
DOI: 10.1016/j.it.2010.04.002
PMC: PMC2891151
OpenAlex: W2130229338
Cited by: 1,023
References: 87
Citations by year: 2026: 35 · 2025: 73 · 2024: 81 · 2023: 82 · 2022: 87 · 2021: 96 · 2020: 85 · 2019: 78 · 2018: 71 · 2017: 51 · 2016: 37 · 2015: 40 · 2014: 49 · 2013: 50 · 2012: 56
FWCI: 4.42
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Trends in Immunology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Cancer Institute (ZIABC011163)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords: TGF-beta, tumor microenvironment, tumor progression, immunosuppression, tumor surveillance, CD8+ T cells, natural killer cells, neutrophils, chemokines, cancer-associated fibroblasts, TGF-beta antagonists
MeSH terms: Animals, Humans, Killer Cells, Natural, Neoplasms, T-Lymphocytes, Signal Transduction, Transforming Growth Factor beta, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks